From January 1, 2023 to February 10, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 109,064 shares, representing 0.89% for KRW 9,895.01 million under the buyback announced on February 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,03,600 KRW | +0.48% | -0.67% | -20.86% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.86% | 969M | |
+20.83% | 43.57B | |
+22.27% | 22.7B | |
+16.41% | 14.32B | |
+11.11% | 13.42B | |
+45.91% | 11.83B | |
-6.86% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.51B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.